BIOMAT Database Logo BIOMAT Database Logo

Intrarenal formation of angiotensin II in the rat: interference by Saralasin and SQ 20881. 1975

H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012504 Saralasin An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION. 1-Sar-8-Ala Angiotensin II,1-Sarcosine-8-Alanine Angiotensin II,(Sar(1),Ala(8))ANGII,(Sar1,Val5,Ala8)Angiotensin II,Angiotensin II, Sar(1)-Ala(8)-,Angiotensin II, Sarcosyl(1)-Alanine(8)-,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,Saralasin Acetate,Saralasin Acetate, Anhydrous,Saralasin Acetate, Hydrated,1 Sar 8 Ala Angiotensin II,1 Sarcosine 8 Alanine Angiotensin II,Angiotensin II, 1-Sar-8-Ala,Angiotensin II, 1-Sarcosine-8-Alanine,Anhydrous Saralasin Acetate,Hydrated Saralasin Acetate
D013722 Teprotide A synthetic nonapeptide (Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) which is identical to the peptide from the venom of the snake, Bothrops jararaca. It inhibits kininase II and ANGIOTENSIN I and has been proposed as an antihypertensive agent. BPP-9a,Bradykinin-Potentiating Peptide 9a,Nonapeptide-Converting Enzyme Inhibitor,SQ-20881,Bradykinin Potentiating Peptide 9a,Enzyme Inhibitor, Nonapeptide-Converting,Nonapeptide Converting Enzyme Inhibitor,Peptide 9a, Bradykinin-Potentiating
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Saralasin and SQ 20881 : their effects on central nervous system norepinephrine.
February 1978, Archives internationales de physiologie et de biochimie,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Acute reversal by saralasin of multiple intrarenal effects of angiotensin II.
November 1979, The American journal of physiology,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Thermal responses to central angiotensin II, SQ 20881, and dopamine infusions in sheep.
March 1985, The American journal of physiology,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animals.
July 1973, European journal of pharmacology,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Intrarenal formation of angiotensin II.
January 2001, Contributions to nephrology,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Substance P degradation by rat brain peptidases: inhibition by SQ 20881.
January 1979, Biochemical pharmacology,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Angiotensin-converting enzyme inhibitor (SQ 20881) in the diagnosis of renovascular hypertension.
February 1979, Angiology,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Inhibition of brain angiotensin-1 converting enzyme by Bothrops jararaca nonapeptide (SQ 20881) and a prolyl analog (SQ 14225).
June 1978, Journal of neurochemistry,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
[Intrarenal mechanisms of angiotensin II formation].
January 2010, Nihon Jinzo Gakkai shi,
H Zschiedrich, and K G Hofbauer, and E Hackenthal, and G D Baron, and F Gross
Effect of angiotensin-converting enzyme inhibitor (SQ 20881) on the plasma concentration of angiotensin I, angiotensin II, and arginine vasopressin in the dog during hemorrhagic shock.
September 1977, Circulation research,
Copied contents to your clipboard!